Home > Boards > US Listed > Biotechs >

Achilles Therapeutics Plc (ACHL)

ACHL RSS Feed
Add ACHL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/17/2022 6:23:10 PM - Followers: 2 - Board type: Free - Posts Today: 0

ACHL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACHL News: Chardan Capital Thinks Achilles Therapeutics’ Stock is Going to Recover 05/02/2022 04:15:18 AM
ACHL News: The Center for Breakthrough Medicines (CBM) Strikes Multi-Year Deal with UK Cell Therapy Powerhouse 04/12/2022 03:30:00 AM
ACHL News: Achilles Therapeutics Selects Netrality’s 401 North Broad for United States Headquarters 03/01/2022 04:00:00 AM
ACHL News: Achilles Therapeutics GAAP EPS of -$0.45 beats by $0.31 03/01/2022 02:53:07 AM
ACHL News: Statement of Ownership (sc 13g) 02/14/2022 12:29:37 PM
PostSubject
#32   Link to webcast https://onlinexperiences.com/scripts/Server.nxp?LASCmd=AI%3A4%3B jondoeuk 04/17/22 06:23:10 PM
#31   AI model will be great for diagnosis, chronic NY1972 04/13/22 08:17:11 PM
#30   The data model is not biased compared to NY1972 04/13/22 08:11:23 PM
#29   I do think AI is overhyped, but not jondoeuk 04/13/22 06:38:44 PM
#28   Deep learning is hype. AI is modeling if NY1972 04/13/22 04:42:16 PM
#27   PELEUS was designed and trained on validated data jondoeuk 04/11/22 06:05:56 PM
#26   bounced off the low from Mar 07 2022 2.7301 G2G 04/06/22 11:23:00 AM
#25   It took 40 years for neural network to NY1972 04/05/22 02:25:35 PM
#24   5055 - Precise segmentation of growth patterns in jondoeuk 04/04/22 06:33:36 PM
#23   The company will host a KOL webcast & jondoeuk 04/04/22 06:18:11 PM
#22   ADXS also found numerous frame shift mutations common NY1972 01/25/22 09:48:54 PM
#21   No, but the data its trained on is jondoeuk 01/25/22 07:07:22 PM
#20   Computer prediction has not worked for ADXS and NY1972 01/24/22 03:11:42 PM
#19   PELEUS was designed and trained using TRACERx data. jondoeuk 01/23/22 03:19:54 PM
#18   Looking at sitc poster, 2 pts were dosed NY1972 01/20/22 06:11:39 PM
#17   New PR https://www.globenewswire.com/news-release/2021/12/09/2349042/0/en/Achill jondoeuk 12/09/21 05:49:35 PM
#16   ACHL is making progress while GNCA is running NY1972 11/13/21 09:49:14 PM
#15   From the PR: ''The data we presented today jondoeuk 11/12/21 12:41:51 PM
#14   SITC posters https://ir.achillestx.com/static-files/72b85326-1980-405e-91f3-cbb5 jondoeuk 11/12/21 11:27:25 AM
#13   Slides https://ir.achillestx.com/static-files/d043ce81-400b-4da5-90b0-21e2fe8c8b jondoeuk 11/12/21 11:25:58 AM
#12   SITC and corporate update webcast https://edge.media-server.com/mmc/p/hrieccnt jondoeuk 11/11/21 01:02:53 PM
#11   What do you think about the tech? jondoeuk 11/08/21 06:46:57 PM
#10   What do you think about the tech? Valuation SweatpantKing 10/30/21 11:23:31 PM
#9   The company shared initial data from its Material jondoeuk 10/22/21 02:20:11 PM
#8   European Society for Gene and Cell Therapy (ESGCT) Congress: jondoeuk 10/01/21 12:29:15 PM
#7   The company has enrolled the first US patient jondoeuk 07/01/21 12:28:20 PM
#6   The primary objective of the trial is to jondoeuk 06/22/21 01:22:36 PM
#5   The poster https://ir.achillestx.com/static-files/645c95d7-bdbe-438a-9ca2-98b57e jondoeuk 06/04/21 01:16:15 PM
#4   ASCO abstract (TIP) https://meetinglibrary.asco.org/record/201330/abstract jondoeuk 05/27/21 12:52:56 PM
#3   BofA Securities webcast https://www.veracast.com/webcasts/bofa/hc2021/idmW5F21.c jondoeuk 05/27/21 12:51:42 PM
#2   In a case study from the ongoing THETIS jondoeuk 05/14/21 05:04:18 PM
#1   This year there will be interim data from jondoeuk 05/14/21 05:01:23 PM
PostSubject
Consent Preferences